Imunon, Inc. (NasdaqCM: IMNN)
Health Care · Biotechnology · US
$1.02
-5.56% today · -80.0% 1Y
Imunon, Inc. (NasdaqCM: IMNN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.72M and employs 20 people.
Over the last twelve months the share price has lost 80.0%, trading between 0.96 and 5.25.
Tweenvest scores Imunon, Inc. across four factors: quality 45/100, value 66/100. Its strongest factor is value.
IMNN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.72M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.57
- Dividend yield
- —
- Beta (5Y)
- 2.01
- 52-week high
- $5.25
- 52-week low
- $0.96
- Avg volume (3M)
- —
- Shares outstanding
- 5.61M
- Employees
- 20
- Next earnings
- —
About Imunon, Inc.
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.
- ISIN
- US15117N7012
- Founded
- 1982
- Listed since
- Mar 1, 1999
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Niki BioSolutions, Inc.NasdaqCM: NIKI | $5.97M | $2.03 | -49.25% |
| Can-Fite BioPharma Ltd.TASE: CANF | $5.94M | ₪3.04 | -3.00% |
| Cizzle Biotechnology Holdings PlcLSE: CIZ | $5.81M | £0.01 | -29.31% |
| OLIPASS CorporationKOSDAQ: A244460 | $5.72M | ₩— | — |
| AquaBounty Technologies, Inc.NasdaqCM: AQB | $5.71M | $1.11 | +8.82% |
| NeuroSense Therapeutics Ltd.NasdaqCM: NRSN | $5.68M | $3.07 | -16.12% |
| Quantum Genomics Société AnonymeENXTPA: ALQGC | $5.65M | €0.07 | -0.28% |
| LianMedicalOTCPK: LIAN.Y | $5.52M | $0.05 | -12.45% |
Figures last refreshed Oct 18, 2026.